Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001677455-25-000005

EVP and Chief Legal Officer sold 2,450 shares at $31.17 ($76,367)

From the SEC's structured data for this filing

Trades in this filing

Parschauer Karah Herdman · EVP and Chief Legal Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-09-12 Sale : show line 1 in the form −2,450 $31.17 $76,367 73,271 D
Open-market sales · 2,450 sh · avg $31.17 · $76,367
Loading xslF345X05/ownership.xml…